Progress in the Application of Brain Natriuretic Peptide in Chronic Obstructive Pulmonary Disease

Jianhua SU,Kewen CHENG,Xiaodong CHEN
DOI: https://doi.org/10.3969/j.issn.1006-2084.2017.23.019
2017-01-01
Abstract:Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by progressive persistent airflow limitation.Brain natriuretic peptide (BNP) is secreted mainly by the ventricles,and ventricular pressure increases its secretion,which is an effective monitoring index of congestive heart failure,and a number of diseases can cause elevated levels of BNP.In addition to understanding the role of BNP in the diagnosis of heart failure,the current study can also understand the condition of COPD through monitoring the BNP levels changes in plasma in patients with different treatment conditions.Therefore,to further understand BNP in the clinical application and prognosis evaluation of COPD patients may provide new ideas for the diagnosis and treatment of COPD patients.
What problem does this paper attempt to address?